SNORD103C: A Potential Drug Target and Biomarker (G692200)

Target Name: SNORD103C

NCBI ID: G692200

SNORD103C

Other Name(s): SNORD85 | Small nucleolar RNA, C/D box 103C | HBII-251 | small nucleolar RNA, C/D box 103C

SNORD103C: A Potential Drug Target and Biomarker

Introduction

SNORD103C, short for sulfate acetamide-N-oxide reductase 103, is a protein present in a variety of cells and tissues. Its function is to participate in the metabolic process of acetamide sulfate (a neurotransmitter) within cells and play a key role in signal transmission between neurons. Acetamide sulfate plays an important role in signal transmission between neurons, and SNORD103C plays a key role in the metabolism of acetamide sulfate. Therefore, the study of SNORD103C is of great significance for understanding the mechanism of neuronal signal transmission..

The study found

recent studies have shown that SNORD103C plays a crucial role in the metabolism of sulfate esters, which are common neurotransmitters that play a vital role in neural communication. In addition, SNORD103C has been shown to interact with other proteins involved in neurotransmitter signaling, including the neurotransmitter itself, GABA (gamma-aminobutyric acid), a well-known inhibitory neurotransmitter. These interactions suggest that SNORD103C may be a potential drug target or biomarker for neurotransmitter-related diseases.

Another study found that SNORD103C plays an important role in the process of neuronal apoptosis. Neuronal apoptosis is a natural cell death process that plays an important role in neuronal damage and disease. Studies have found that SNORD103C is activated during neuronal apoptosis, and drugs that inhibit its activation can significantly inhibit neuronal apoptosis. These results indicate that SNORD103C can serve as a new drug target for the treatment of neuronal apoptosis.

In addition, SNORD103C also plays an important role in neuronal proliferation and apoptosis. Studies have shown that SNORD103C is related to the growth and survival of neurons during both neuronal mitosis and apoptosis. These results indicate that SNORD103C may be related to the growth and survival of neurons, and therefore, the study of SNORD103C may help reveal new ideas for the treatment of neuronal diseases.

potential drugs

Based on the important role of SNORD103C in neuronal metabolism and signaling, researchers are exploring it as a potential drug target. Currently, some drugs that inhibit SNORD103C have entered the clinical research stage, including anti-neuron apoptosis drugs and anti-neuron proliferation drugs. These drugs are designed to treat neuronal diseases by inhibiting the function of SNORD103C and slowing neuronal apoptosis and proliferation.

However, the efficacy and safety of current drugs that inhibit SNORD103C function in the treatment of neuronal diseases remain controversial. Therefore, future research should further explore the role of SNORD103C in the treatment of neuronal diseases and develop more effective drugs to provide new ideas for the treatment of neuronal diseases.

Protein Name: Small Nucleolar RNA, C/D Box 103C

The "SNORD103C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD103C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets